Mentice Q1 2025 delårsrapport webcast
Anmäl dig nu
Mentice publicerar årsredovisning 2024
Läs mer
Mentice får en total order på avancerade simuleringslösningar värd $648,410 USD från ett topp 20 globalt medtech bolag
Läs Mer
.png)
Magnus Nilsson
Chairman of the Board
Chairman of the Remuneration Committee
Born 1956. Doctor of Medical Science (Med Dr Sc) from Uppsala University. Currently, Senior Advisor, XVIVO Perfusion Inc. Other Board assignments: board member at Cantargia AB and Corline AB. Earlier President and CEO, Xvivo Perfursion AB, President and CEO, Vitrolife AB and board member in the publicly listed Immunicum AB and Dignitana AB.
Holdings
Aktier och optioner
Shareholding in Mentice: 10,000 shares
Independent
Oberoende
Independent in relation to the company, its management, and major shareholders.
